RAPT Therapeutics Cash from Investing (TTM) Insights

RAPT Therapeutics Inc (RAPT)

8.175 +0.48 (+6.17%) USD | NASDAQ | May 01, 16:00

8.175 0.00 (0.00%) After-Hours: 17:47

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	104.13M
September 30, 2023	42.22M
June 30, 2023	-1.124M
March 31, 2023	-44.02M
December 31, 2022	-45.49M
September 30, 2022	-20.11M
June 30, 2022	-16.69M
March 31, 2022	-69.92M
December 31, 2021	-81.35M
September 30, 2021	-49.96M
June 30, 2021	-34.73M

Date	Value
March 31, 2021	-28.04M
December 31, 2020	-87.44M
September 30, 2020	-102.91M
June 30, 2020	-104.05M
March 31, 2020	-47.40M
December 31, 2019	-0.843M
September 30, 2019	-2.517M
June 30, 2019	-3.237M
March 31, 2019	-3.482M
December 31, 2018	-3.50M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-104.05M

Minimum

Jun 2020

104.13M

Maximum

Dec 2023

-31.24M

Average

-34.73M

Median

Jun 2021

Cash from Investing (TTM) Benchmarks